During his session at the InterPro AFib Forum, Christian T. Ruff, MD, MPH, from Brigham and Women's Hospital, spoke about managing antithrombotic therapy in AFib and CAD.
Brendan M. Everett, MD, MPH, from Harvard Medical School answers our questions about his session at the World Congress Insulin Resistance Diabetes & Cardiovascular Disease conference.
Considering pharmacotherapy for your patient with obesity? Here’s what you should know, according to Harold Bays, MD, who presented “Current and Future of Obesity Drug Therapies: Echoes of Today’s Metabolic...
“Primary care providers are increasingly called upon to recognize and treat heart failure early in their patients”, said Keith C. Ferdinand, MD, during his presentation at CRS 2018, “Update in the...
A new study examined the connection between mental health conditions and hypertension among US women. Consultant360 spoke with the lead author of the study for more information.
Dr Jaimin Trivedi and colleagues presented their research at the Heart Rhythm Scientific Sessions 2018 last month. Now, Dr Trivedi is answering our questions about devices in heart failure.
Consultant360 recently spoke with Wesley O’Neal, MD, regarding his latest research about the link between provider specialty, anticoagulation prescription patterns, and stroke risk in patients with atrial...
Recently, Consultant360 spoke with Dr Wilbert S. Aronow, who was part of the panel that constructed the new hypertension guidelines, about the factors that help determine appropriate treatment options for...
Dr. James Matera, nephrologist and co-director of physician integration, answers questions about cardiometabolic risk in the United States as well as management of patients with chronic kidney disease. ...
